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Abstract
Background: HIV infection causes a relative immunodeficient state, potentially predisposing patients to osseous infection. It is also
associated with non-AIDS defining cancers, and has been described in patients with limb girdle sarcomas and malignant fibrohistiocytic
tumours. HIV is further known to suppress cells important in bone healing; however, it is unclear whether bone tumours and mal- or
non-unions are more prevalent in patients with HIV. This study aimed to determine the HIV seroprevalence of patients attending a 
tumour, sepsis and reconstruction (TSR) unit, and explore its relationship to bone infection, bone tumours and patients undergoing
limb reconstruction.
Methods: A retrospective review of all adult patients treated over a three-year period was performed. Patients were stratified according
to pathology into bone infection, bone tumour, and limb reconstruction categories. Each patient had an opt-in HIV test as part of
routine workup. Recruitment, prevalence and statistically significant relationship were then calculated relative to the HIV-uninfected
cohort. 
Results: Nine-hundred-and-six patients were included, 21.3% of whom were HIV positive. There were 313 patients with bone infection,
263 patients with bone tumours, and 330 limb reconstruction patients. All groups were similar in HIV prevalence. There was no 
statistically significant difference between the HIV-positive or -negative patients in any of the groups. 
Conclusion: This series found no significant difference in the incidence of bone infections, bone tumours or the need for limb 
reconstruction, between HIV-positive and -negative patients. 
Level of evidence:  Level 4
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Introduction
Infections with the human immunodeficiency virus (HIV) remain an 
epidemic in Southern Africa. Mid-year population estimates from 2013
indicate 10% of the almost 53 million people in South Africa are 
infected with HIV.1 KwaZulu-Natal has the highest infection rate with
over 21% of adults between the ages of 15 and 49 years infected.2
Furthermore, the virus’s primary effect of immunodeficiency 
predisposes to protean disorders that affect all body systems. 
Naturally in-hospital seroprevalence rates reflect this, with some 23–
32.8% of inpatients HIV positive.3-5
HIV management has advanced significantly over the last 20 years,
chiefly through the advent of antiretroviral medication. This has 
restored immunocompetency such that there is an increased longevity
and overall life quality.6 Despite these advancements it remains a 
relative immunodeficient state with increased susceptibility to 
infections and tumours.7,8 Most notably in relation to skeletal disease,
HIV suppresses lymphocytes and macrophages that are known to be
important in both bone healing9,10 and resistance to bacterial 
infection,11 potentially making patients more susceptible to osseous
infections, delayed unions, malunions and non-unions.
South Africa’s high burden of trauma further exacerbates these 
issues. Motor vehicle collisions and interpersonal violence account for
the majority of injuries,12 frequently resulting in open or closed fractures
that require internal or external fixation. This places a great number of
people at risk of skeletal infection and similarly increases the likelihood
of patients requiring limb reconstruction.
The relationship between HIV infection and bone infection, bone
tumours or the requirement for limb reconstruction is difficult to 
accurately elucidate, and consequently is not well defined. First, 
accurate recording of HIV seroprevalence is not simple. Many 
studies reflect low recruitment rates,3,13-15 often because of stigma
or fear of the disease, skewing true prevalence rates. Specific to 
infection, it remains unclear if HIV infection results in an increased
risk for the development of chronic osteomyelitis. Older studies 
suggest an increased risk of infection in HIV-seropositive individuals
treated with internal fixation for open16,17 and closed18 fractures,
while more recent literature has noted no difference or contra-
indication to internal fixation in open or closed fractures.19,20
The question of accurate quantification of HIV seroprevalence in the
orthopaedic population and its relation to chronic biofilm-based 
infections, bone tumours or the requirement for limb reconstruction
remains unresolved. This study aimed to investigate HIV 
seroprevalence in a tertiary tumour, sepsis and reconstruction (TSR)
unit and explore its relationship to bone infection, bone tumours and
patients undergoing limb reconstruction.
Materials and methods
We performed a retrospective review of a cross-sectional cohort of
patients treated at the TSR unit of a tertiary referral centre that drains
the greater part of northern and western KwaZulu-Natal. Ethical 
approval was obtained from the institutional ethics committee before
commencement of the study. All patients that were treated between
1 August 2011 and 1 August 2014 were included. Eligible patients
were identified from a prospectively collected database. Patients were
excluded if they were under 18 years of age or had an arthroplasty-
related periprosthetic infection. 
All patients seen were host stratified, with an opt-in HIV test part of
the routine work up. HIV status was recorded where permission for
the test was obtained. A positive diagnosis was subsequently affirmed
with an ELISA, and appropriate staging, post-test counselling and 
initiation of therapy where appropriate, begun.
Patients were stratified according to pathology into bone infection,
bone tumour, and limb reconstruction categories. The bone infection
category included all cases of chronic osteomyelitis, defined by 
Waldvogel and Lew as bone infection being present for more than ten
days’ duration.21 Cases of osteoarticular tuberculosis were also 
included. The tumour category included benign and primary malignant
bone tumours, secondary metastases and soft tissue sarcomas of
the limbs and limb girdles. Limb reconstruction patients consisted of
aseptic mal- or nonunions, and other limb alignment and length 
discrepancies requiring deformity correction or bone transport. 
HIV status was recorded and expressed as prevalence in 
percentage. Any relationship per diagnostic category was then 
assessed using Pearson’s chi-squared test. The null hypothesis was
that there was no significant difference between the groups, with a 
p-value significance level set to 0.05.
Results
A cohort of 906 consecutive adult patients was identified from the
prospectively collected database. Of these, 193 patients (21.3%)
were HIV positive, 597 patients (65.9%) were HIV negative and 
116 patients (12.8%) recorded an unknown status (Figure 1). A total
of 790 patients gave consent to be tested, resulting in 87.2% 
recruitment.
Further, there were approximately equal numbers of patients 
in each of the three pathological categories. Three-hundred-and-
thirteen patients (34.6%) were treated for bone infection, 263 
patients (29.0%) were treated for primary or secondary tumours of
bone or soft tissue sarcomas, and 330 patients (36.4%) underwent
some form of limb reconstruction (Figure 2). 
The HIV prevalence in each pathology category was also similar.
In the infection group, 77 (24.5%) were HIV positive, 202 (64.6%)
HIV negative and 34 (10%) were HIV unknown. In the tumour group,
53 (20.6%) were HIV positive, 177 (67.3%) HIV negative and 
33 (12.6%) were HIV unknown. In the limb reconstruction group,
63 (19.1%) were HIV positive, 218 (66.1%) HIV negative and 
49 (14.8%) were HIV unknown (Table I).
As demonstrated in the contingency table (Table II), overall there
was no significant difference between any of the groups (p=0.320).
When assessing each category relative to the combined others,
for each of bone infection, tumours and limb reconstruction there
was no significant difference between any of the groups (bone 
infection p=0.225; tumours p=0.236; limb reconstruction p=0.835).
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Discussion
The aim of this study was to determine the prevalence of HIV 
infection in a cohort of patients diagnosed with chronic bone 
infection, bone tumours or conditions requiring limb reconstruction.
The overall HIV prevalence was 21.3%, but importantly there was
no statistically significant difference in HIV prevalence for any of the
pathological categories, suggesting that HIV infection does not 
increase the risk for these conditions. This study also reflected an
87.2% recruitment rate, which strengthens its extrapolation to the
broader public. 
This recruitment is most likely due to the widespread public 
awareness campaigns that have resulted in increased awareness
of HIV, demystifying much of the unknown about the disease and
reducing the associated stigma.22 This, combined with the 
knowledge that more effective treatment has become available,
probably increased the willingness of patients to undergo HIV 
testing.
The association between HIV infection and chronic osteomyelitis
is not well defined. Several conflicting studies have been published.
Initial reports noted an increased risk of post-operative infection
while more recent studies failed to support these findings. In 1991
Hoekman et al. found an increase in the risk of post-operative 
infection following surgical fracture fixation in symptomatic (defined
as CDC stage III or IV) HIV-infected individuals.18 Jellis reported a
33% infection rate following internal fixation of closed fractures and
a 72% infection rate in open fractures.23 Noteworthy is the fact that
Jellis reported an increase in adult haematogenous osteomyelitis
and late implant-related infections as patients’ immune competency
decreased.23 In 2002 Harrison et al. also found a significant increase
in early wound infection following open fractures in HIV-positive 
patients.17 The incidence of early wound sepsis following internal
fixation of closed fractures was however not increased in this series.
Harrison and colleagues then also investigated the prevalence 
of late infection and found no implant-related infection in 26 HIV-
positive patients, at one year follow-up.24
A subsequent study, from the same centre in Malawi, again failed
to show an increased risk of early wound infection in clean surgery,
but found that the infection rate had doubled in contaminated
wounds.20 Contrary to the findings of Jellis, this study did not show
an increase in chronic infections in HIV-positive patients. Two further
studies from KwaZulu-Natal, South Africa, added to the controversy.
The first noted an increased risk of infection in open fractures in 
patients with advanced HIV disease (CD4 < 350 cells/μl).19 The 
second study failed to show an increase in early wound infection in
HIV-positive patients with open tibia fractures.25
The evidence available, therefore, appears to be contradictory in
terms of the development of infection in both open and closed 
fractures. However, most of these studies were designed to look at
HIV as a risk factor for early wound infection rather than the 
development of chronic osteomyelitis. Moreover, it is not known if
HIV infection resulted in an increased risk of reactivation of chronic
haematogenous osteomyelitis. The results of our study appear to
indicate that HIV is not a risk factor for developing chronic 
osteomyelitis.
Several malignant tumours have been associated with HIV/AIDS
including the AIDS-defining cancers (ADCs) such as Kaposi’s 
sarcoma, non-Hodgkin’s lymphoma and cervical cancer.26 The 
relative incidence of certain non-AIDS defining cancers (NADCs)
have also increased, including Hodgkin’s lymphoma, liver, lung, anal
and skin cancer.27 In addition, HIV is associated with an increased
risk for the development of plasma cell disorders like multiple
myeloma.28 In terms of sarcomas other than Kaposi’s, it appears
that leiomyosarcoma and angiosarcoma may occur dispropor-
tionately in HIV-positive patients. Furthermore, osteosarcoma,
rhabdomyosarcoma and malignant fibrohistiocytic tumours have
been reported in HIV-positive patients.29 In this series, however,
the overall incidence of bone and soft tissue tumours was not 
increased in the HIV-positive group. It is, however, still possible
that the prevalence of certain tumours may be increased in the
HIV-positive group and this effect may be hidden by the increased
incidence of other tumours in age groups with a lower HIV 
prevalence. Further research is required in this regard.
Limb reconstruction cases generally consisted of non-union, 
malunion and bone defect management. HIV infection has traditionally
been implicated as a risk factor for non-union development but the
evidence remains contradictory. Union rates between HIV-positive and
HIV-negative patients who sustained closed fractures appear 
comparable.30,31 Union rates following open fractures, however, is
more controversial. Chandanwale et al., and Aird et al. both found an
increased risk of non-union in HIV-positive patients compared to 
HIV-negative patients.30,32 The current series failed to show that 
HIV-infected individuals required more limb reconstruction surgery
when compared to HIV-negative individuals.
There are some limitations of this study that need to be noted.
Data with regard to epidemiology and the specific diagnosis was
incomplete and thus not included in the analysis. The lack of CD4
count data represents a shortcoming as previous studies have 
suggested an increased rate of infection in patients with very low
CD4 counts. Subgroup analysis by CD4 count may have shown an
increased incidence of chronic osteomyelitis in the severely 
immunosuppressed individuals. This risk is somewhat mitigated by
the specific hospital policy to place those patients with first 
diagnoses and low CD4 counts on treatment rapidly. Further, 
patients with CD4 counts below 350 were not operated on, 
excepting in emergencies. Hence the absolute number of patients
with severe immunosuppression was likely very low. 
With respect to tumours, no differentiation between primary and
secondary bone malignancies was made. Although our results 
contrast the literature, which generally purports that HIV increases
the risk for development of most cancers,33,34 it is possible that the
study group contained a low number of patients with secondary
bone tumours, which are the lesions commonly reported to occur
with increased frequency in HIV-infected individuals.8
Table I: Patient numbers (and percentage) in each of the bone infection,








HIV positive 77 (24.5%) 53 (20.6%) 63 (19.1%)
HIV negative 202 (64.6%) 177 (67.3%) 218 (66.1%)
HIV unknown 34 (10.9%) 33 (12.6%) 49 (14.8%)
Totals 313 263 330
Table II: Contingency table used to calculate Pearson’s chi value
(highlighted in blue) and the subsequent p value
HIV
Diagnosis
Infections Tumours Limbreconstruction Total
Positive
77  53 63 193
1.6   0.2 0.8 2.5
Negative
202   177 218 597
0.1  0.1 0.0 0.2
Unknown
34   33 49 116
0.9   0.0 1.1 2.0
Total
313 263 330 906
2.6  0.3 1.8 4.7
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Lastly, by excluding children, a number of primary osteosarcoma
patients was not captured. This is a very difficult group of patients
to study due to low absolute numbers, the issues related to consent
for HIV testing, and whether HIV infection was acquired perinatally
or later (as these are two different groups of patients in and of 
themselves).
Conclusion
In this series, we found no significant difference in the incidence
of bone infections or tumours, as well as the need for limb 
reconstruction, between HIV-positive and -negative patients. 
Current evidence fails to predict an increased rate of complications in
HIV-positive patients and therefore it appears reasonable to expect
similar complication rates if HIV patients are treated according to 
standard treatment protocols. Further research in this field is 
recommended.
Compliance with ethics guidelines
Ethical approval was obtained from the institutional ethics committee
before commencement of the study.
Human rights: All procedures followed were in accordance with
the ethical standards of the responsible committee on human 
experimentation (institutional and national) and with the Helsinki
Declaration 1975, as revised in 2008. Informed consent was 
obtained from all patients prior to undergoing an HIV test.
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